KYSA-8

· Kyverna Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KYSA-8, covering 2025-12-22 to 2025-12-22. Get the full timeline:

Most recent: Clinical Trial Update: KYSA-8: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Treatment Refractory Stiff Person Syndrome [Phase 2]

See pricing